Sánchez-Serna J, Pérez-Martínez MT, Asensio-López MC, Casas T, Noguera JA, Pascual-Figal DA. Short-term Serial Measurement of Galectin-3 in Hospitalized Patients With Acute Heart Failure. Rev Esp Cardiol (Engl Ed). 2018 May;71(5):401-402. doi: 10.1016/j.rec.2017.03.013. Epub 2017 May 1. English, Spanish. PubMed PMID: 28473265.
AÑO: 2018; IF: 5.126
|
Asensio-Lopez MDC, Lax A, Fernandez Del Palacio MJ, Sassi Y, Hajjar RJ, Pascual-Figal DA. Pharmacological inhibition of the mitochondrial NADPH oxidase 4/PKCα/Gal-3 pathway reduces left ventricular fibrosis following myocardial infarction. Transl Res. 2018 Sep;199:4-23. doi: 10.1016/j.trsl.2018.04.004. Epub 2018 Apr 23. PubMed PMID: 29753686.
AÑO: 2018; IF: 4.915
|
Pascual-Figal DA, Pérez-Martínez MT, Asensio-Lopez MC, Sanchez-Más J, García-García ME, Martinez CM, Lencina M, Jara R, Januzzi JL, Lax A. Pulmonary Production of Soluble ST2 in Heart Failure. Circ Heart Fail. 2018 Dec;11(12):e005488. doi: 10.1161/CIRCHEARTFAILURE.118.005488. PubMed PMID: 30562096.
AÑO: 2018; IF: 6.526
|
Zannad F, Anker SD, Byra WM, Cleland JGF, Fu M, Gheorghiade M, Lam CSP, Mehra MR, Neaton JD, Nessel CC, Spiro TE, van Veldhuisen DJ, Greenberg B; COMMANDER HF Investigators. Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease. N Engl J Med. 2018 Oct 4;379(14):1332-1342. doi: 10.1056/NEJMoa1808848. Epub 2018 Aug 27. PubMed PMID: 30146935.
AÑO: 2018; IF: 70.67
|
Fernández Gassó ML, Hernando-Arizaleta L, Palomar Rodríguez JA, Pascual-Figal DA. Analysis of Hospitalization Trends for Heart Failure in the Health Registries of Different Autonomous Communities. Rev Esp Cardiol (Engl Ed). 2018 Feb;71(2):128-129. doi: 10.1016/j.rec.2017.09.005. Epub 2017 Nov 27. English, Spanish. PubMed PMID: 29191781.
AÑO: 2018; IF: 5.126
|